Category: Workers Comp

599 posts found

Generic Drug Tariffs Announced for 2028

A 100% tariff will take effect August 1, 2028 for generic drugs imported into the U.S., followed by a 200% tariff in August 2029.

This Month's Must Read

6 Steps for More Effective Pharmacy Workflows

Effective pharmacy workflows pair greater efficiency with better health outcomes, reducing burden for claims professionals while increasing impact.

Industry Insights

WCRI Reports on Trends in Non-Price-Controlled Medical Services

The study focused on DME and professional services billed by nonhospital providers from January 1, 2019 through June 30, 2025.

image of New York state statue of liberty

Legislation & Policy

New York Broadens Pay Without Prejudice Rules

Effective January 1, 2027, payers may voluntarily cover medical treatment for up to one year while compensability determination is under review.

Psychedelic drugs and laboratory imagery

Psychedelic Developments

FDA Seeks Input on Potential Therapeutic Use of Psychedelic Drugs

A public hearing will be held on September 14th, with written comments accepted until October 5th.

Healthe Developments

In Person, In Print, and On Stage: Connect with Healthe at National Comp 2026!

Visit Healthe at Booth #415 to chat and pick up a copy of RxInformer magazine, or sit in on our panel discussion.

Medmonitor

FDA Approves Rextovy as OTC for Opioid Overdose

This approval marks the third OTC naloxone medication available for the treatment of opioid overdose.

This Month's Must Read

Deep Breath: Occupational Lung Disease and Pharmacy Management

These diseases are infrequent, but they can incur significant costs as they can be present for life, requiring ongoing monitoring, treatment, and medication.

Image of A doctor handing a patient medication

Legislation & Policy

State Activity Surrounding Physician Dispensing

Florida, Pennsylvania, and Michigan have recently made waves regarding physician dispensing.

Industry Insights

Migraine Drugs Are Now Number Three in Drug Spend in California

While migraine drugs make up less than 1% of prescriptions, they now make up 7.5% of drug spend, primarily driven by CGRP drugs.

Psychedelic Updates

Emerging Therapies: Phase 3 Data for LSD-Based Drug in Major Depression

Patients taking DT120 for major depressive disorder experienced significant drops in depression symptoms.

Healthe Developments

Healthesystems at WCI 2026

Visit Healthe at Booth #921, and don’t forget to check out two educational sessions featuring Healthe leaders!

Medmonitor

Can GLP-1 Drugs Lower Cancer Risks?

While experts agree more research is needed, several studies have noted patients on these drugs showed reduced rates of certain types of cancer.

This Month's Must Read

Escalating Costs: Trends in Durable Medical Equipment (DME)

Demand for DME is rising, as are costs. What’s driving this growth, and how can the workers’ compensation industry contain costs?

image that represents state legislatures

Legislation & Policy

Presumption Expansions Throughout the Country

Several states continue to update presumptions for cancer, PTSD, and other conditions.

1 2 3 4 5 … 36 37 38 39 40 Next